The estimated Net Worth of Venture Fund Vi Lp Atlas Ve... is at least $429 Million dollars as of 2 March 2012. Venture Ve owns over 828,443 units of Horizon Therapeutics Plc stock worth over $428,948,592 and over the last 13 years Venture sold HZNP stock worth over $0.
Venture has made over 1 trades of the Horizon Therapeutics Plc stock since 2012, according to the Form 4 filled with the SEC. Most recently Venture bought 828,443 units of HZNP stock worth $2,998,964 on 2 March 2012.
The largest trade Venture's ever made was buying 828,443 units of Horizon Therapeutics Plc stock on 2 March 2012 worth over $2,998,964. On average, Venture trades about 828,443 units every 0 days since 2012. As of 2 March 2012 Venture still owns at least 3,688,294 units of Horizon Therapeutics Plc stock.
You can see the complete history of Venture Ve stock trades at the bottom of the page.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over $454,905,275 worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth $58,823,653 . The most active insiders traders include Jeff Himawan, Woodlands Health Ventures F..., and Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of $12,248,018. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth $351,691.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: